# CALCIUM GLUCONATE IN SODIUM CHLORIDE
> **ANDA219037** · Abbreviated New Drug Application (Generic) · Sponsor: MILLA PHARMS · Approved 2026-08-28
## Drug
- **FDA Application Number:** ANDA219037
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CALCIUM GLUCONATE IN SODIUM CHLORIDE
- **Generic name:** Calcium Gluconate
- **Active ingredients:** CALCIUM GLUCONATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MILLA PHARMS
- **First approval:** 2026-08-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219037)
---
*MORVS · CC0 1.0*